Orthopedic and Spine Leader Added to Camber’s Growing Team of Expert Spinal Device Sales Professionals
KING OF PRUSSIA, Pa.–(BUSINESS WIRE)–#CamberSpine—Camber Spine, a leading innovator in spine and medical technologies, has named Mark Nixon as its new Vice President of Sales for the Eastern United States. Nixon brings 25 years of professional sales, marketing, and business development experience, with service to the industry spanning orthopedic, spine, and biologic markets.
Nixon launched his medical device career at Smith & Nephew, with subsequent roles of increasing managerial responsibility at Zimmer Biomet, The Straumann Group, AlloSource, and Life Spine. Nixon holds a bachelor’s degree in public administration, an MBA, and ongoing post-graduate studies.
“We are proud to have a sales leadership pro with Mark’s experience and expertise on our growing team at Camber Spine,” said Max Painter, Camber’s Global Vice President of Sales and Marketing. “His track record speaks for itself. He’s a seasoned commercial leader who will help steward and scale our business in the eastern US. We’re excited to have him join our spinal device sales team.”
“Camber Spine’s innovative solutions and product lineup were a natural draw for me,” said Nixon. “I’m excited to join a team who value the benefits of collaborating with and listening to the needs of the surgeon community as well as the sales professionals in the field, especially due to the fact that the products Camber produces are designed by surgeons for surgeons. I look forward to helping commercialize Camber’s robust and compelling product pipeline.”
Innovative spine and medical technology company Camber Spine Technologies is dedicated to creating surgeon-designed solutions in MIS and minimally disruptive access for the treatment of complex spinal pathology. Incorporating state-of-the-art manufacturing, 3-D printing, and an acute sensitivity to patient anatomy, Camber Spine is making quantum leaps in the spinal fusion market. Learn more at CamberMedtech.com.
Contacts
Media Contact: Paul Williams, 310-569-0023, paul@medialinecommunications.com
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…
PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader…
TERN-501 significantly improved the efficacy of a GLP-1 receptor agonist by normalizing energy expenditure, resulting…
MINNEAPOLIS, June 21, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the…
Shrivers Hospice sets a benchmark for quality care in Ohio with prestigious award LOS ANGELES,…